Sreerang Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.00 M
About Sreerang Biotech
Sreerang Biotech Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 August 2020 (Four years and five months 27 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹8.00 M.
Srirangapuri Srikala, Nagaprasad Venigalla, and Praveen Ginugu serve as directors at the Company.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100TG2020PTC142695
-
Company No.
142695
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Aug 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sreerang Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srirangapuri Srikala
|
Director | 11-Aug-2020 | Current |
|
Nagaprasad Venigalla
|
Additional Director | 21-Aug-2023 | Current |
|
Praveen Ginugu
|
Director | 19-Aug-2021 | Current |
Financial Performance of Sreerang Biotech.
Sreerang Biotech Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sreerang Biotech?
In 2021, Sreerang Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Lansum Elite Avenues & Projects LlpNagaprasad Venigalla is a mutual person
Charges (Loans)
₹0.80 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2023 | State Bank Of India | ₹8.00 M | Open |
How Many Employees Work at Sreerang Biotech?
Sreerang Biotech has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sreerang Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sreerang Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
